Currently, there are 59.67M common shares owned by the public and among those 58.75M shares have been available to trade.
The company’s stock has a 5-day price change of -0.61% and -5.86% over the past three months. DLB shares are trading -8.62% year to date (YTD), with the 12-month market performance down to -6.23% lower. It has a 12-month low price of $75.87 and touched a high of $91.01 over the same period. DLB has an average intraday trading volume of 332.12K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.33%, -2.04%, and -4.62% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Dolby Laboratories Inc (NYSE: DLB) shares accounts for 58.52% of the company’s 59.67M shares outstanding.
It has a market capitalization of $7.55B and a beta (3y monthly) value of 0.99. The stock’s trailing 12-month PE ratio is 40.18, while the earnings-per-share (ttm) stands at $1.96. The company has a PEG of 2.51 and a Quick Ratio of 3.42 with the debt-to-equity ratio at 0.02. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.65% over the week and 1.55% over the month.
Analysts forecast that Dolby Laboratories Inc (DLB) will achieve an EPS of 0.59 for the current quarter, 0.85 for the next quarter and 3.91 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.57 while analysts give the company a high EPS estimate of 0.57. Comparatively, EPS for the current quarter was 0.55 a year ago. Earnings per share for the fiscal year are expected to increase by 22.28%, and 12.50% over the next financial year. EPS should shrink at an annualized rate of 16.00% over the next five years, compared to 39.39% over the past 5-year period.
Looking at the support for the DLB, a number of firms have released research notes about the stock. Barrington Research stated their Outperform rating for the stock in a research note on June 03, 2024, with the firm’s price target at $100. Rosenblatt was of a view on May 24, 2022 that the stock is Buy, while Barrington Research gave the stock Outperform rating on August 02, 2021, issuing a price target of $115. B. Riley FBR on their part issued Neutral rating on August 04, 2020.
